Skip to main content
Clinical Trials/ISRCTN53688797
ISRCTN53688797CompletedNot Applicable

Quantitative assessment of myocardial perfusion with magnetic resonance using an intravascular contrast agent: an open label trial

King's College London (UK)0 sites156 target enrollmentStarted: November 13, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
156

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Known coronary artery disease (with or without prior percutaneous revascularisation)
  • 2. Indication for percutaneous coronary intervention (PCI)
  • 3. The subject is 18 years of age or older, either sex
  • 4. The subject is conscious and able to comply with study procedures
  • 5. Written informed consent has been obtained

Exclusion Criteria

  • 1. Contraindications for magnetic resonance imaging (MRI)
  • 2. Contraindications to gadolinium-based contrast agents (known allergies or a contra-indication to gadolinium (Gd) chelates or renal insufficiency)
  • 3. Contraindications to adenosine stress:
  • 3.1. Myocardial infarction less than 3 days
  • 3.2. Unstable angina pectoris
  • 3.3. Severe arterial hypertension
  • 3.4. Asthma or severe obstructive pulmonary disease requiring treatment (chronic obstructive pulmonary disease [COPD])
  • 3.5. Sick sinus syndrome or a symptomatic bradycardia, atrioventricular (AV) block greater than IIa, trifascicular block
  • 3.6. Allergy against vasodilator
  • 3.7. Allergy against gadolinium-based contrast agents or renal insufficiency
  • 3.8. Other contraindications for adenosine or dipyridamole administration
  • 4. The subject has significant cardiac arrhythmia (i.e. atrial fibrillation)
  • 5. Pregnancy
  • 6. Heart failure (New York Heart Association [NYHA] grade IV)
  • 7. The subject's electrocardiogram (ECG) shows prolonged QT interval
  • 8. Severe arterial hypotension (less than 90 mmHg systolic)
  • 9. Claustrophobia

Investigators

Sponsor
King's College London (UK)

Similar Trials